Brain-derived neurotrophic factor (BDNF) is a well characterized neurotrophin that mediates a wide variety of activities in the central nervous system, including neuronal differentiation, neuroprotection, and synaptic plasticity. The canonical Wnt signaling pathway is a critical regulator of embryonic development and homeostasis in adult tissues. Our group and others recently demonstrated that Wnt signaling induces BDNF expression in neurons and glia. However, the precise relationship between BDNF and Wnt signaling pathways is not understood. Here, we investigated Wnt signaling regulation of BDNF at the transcriptional level using a combination of bioinformatics and molecular analyses. Analysis of the BDNF gene promoter identified seven binding motifs for Wntdependent TCF/LEF transcription factors. Furthermore, specific BDNF promoters were induced by the Wnt3a ligand using chloramphenicol acetyl transferase reporter assays and a dominant-negative TCF4 gene reduced Wnt3a-mediated induction. Finally, Wnt3a induced expression of BDNF and other members of the BDNF signaling pathway in glia cells. Therefore, these data indicate that BDNF is a direct target of Wnt signaling, which provides a new insight into the interaction between two essential signaling pathways.
Introduction
Brain-derived neurotrophic factor (BDNF) is a neurotrophic factor that plays important roles in neuronal survival, neurogenesis, differentiation, and neurite growth throughout the central nervous system (CNS) [1] . Multiple types of stimuli are reported to increase BDNF transcript levels, including neuronal activity and tissue injury [1] . During CNS injury, upregulation of BDNF and other prosurvival factors is an intrinsic tissue response that is proposed to protect the remaining neurons from further damage [2, 3] . Glia cells are an important source of BDNF and targeted overexpression of BDNF in glia protects adjacent neurons from degeneration [4, 5] . Because of the significant role of BDNF in neuronal survival, characterizing signaling pathways that regulate BDNF expression in glia will have important implications for understanding neuron-glia interactions. In addition, identifying cross-talk between BDNF and other prosurvival pathways will lead to new insights into potential mechanisms of neuroprotection.
The canonical Wnt signaling pathway regulates a wide range of essential processes in embryonic and adult tissues, including neuroprotection, neuronal differentiation, and synapse formation. Similar to BDNF, Wnt signaling increases in glia during injury [6] , suggesting coordinated regulation. Indeed, the nontypical Wnt activator Norrin induced BDNF in retina glia during N-methyl-D-aspartate-induced damage, and the Wnt3a ligand induced BDNF in a retinal ganglion cell line [7, 8] .
However, the precise relationship between BDNF and Wnt signaling has not been examined.
The biological effects of Wnt signaling are mediated by TCF/LEF transcriptional activators that bind to specific elements in target genes. The N-terminal domain of Wnt-regulated TCF/LEF proteins associates with b-catenin, which allows interaction with specific DNA sequence motifs. There are four TCF genes in vertebrates, TCF1 (also known as TCF7), TCF3 (TCF7L1), TCF4 (TCF7L2), and LEF1, and several isoforms of each protein are created by using alternative translation start sites and differential splicing. The minimal consensus DNA sequence for binding of all TCF/LEF complexes is A/T-A/T-C-A-A-A/T-G [9, 10] . TCF/LEF-binding sites have been identified proximal to and large distances away from the transcription start sites of target genes and multiple binding sites are often found clustered together within a regulatory element of a gene [11] . There is a significant correlation between TCF binding to a target gene and upregulation of the corresponding transcripts [11] , indicating that identification of TCF/LEF-binding motifs within a gene is a good predictor of regulation by the canonical Wnt pathway.
To investigate the relationship between Wnt signaling and BDNF expression, we focused on the regulation of BDNF by Wnt signaling at the transcriptional level. We used a combination of in-silico genomic analyses and experimental confirmations. Our findings indicate that BDNF is a direct target of the canonical Wnt pathway in glia. Therefore, these results characterize the interaction between two important neuroprotective pathways and increase our understanding of the regulation of the BDNF in the CNS.
Methods

Reagents
The MIO-M1 Muller glia cell line [12] , a retina-specific glia type, was cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 100 units/ml of penicillin, and 100 mg/ml of streptomycin at 371C in 5% CO 2 . Purified recombinant Wnt3a was obtained from R&D (Manassas, Virginia, USA) and lithium chloride (LiCl) was from Sigma (St Louis, Missouri, USA). Wnt3a-conditioned media were from mouse L-cells stably expressing Wnt3a (ATCC, Manassas, Virginia, USA) and control-conditioned media lacking Wnt3a were obtained from parental L-cells (ATCC). Both conditioned media were filtered and mixed in a 1 : 1 ratio with normal media before use [7] . All experiments used conditioned media from the same preparation batch to minimize variability.
Promoter analyses
The rat BDNF gene (NM_012513) contains promoters within several of its 5 0 exons. Therefore, the entire 3.9 kb gene and the 1 kb sequences upstream of the transcription start site were downloaded from the University of California, Santa Cruz database and both positive and negative strands were considered. The analysis was implemented by a Perl program, as described previously [13] . Poisson distribution was used to calculate the probability that a motif occurs in a particular sequence [13] .
Quantitative polymerase chain reaction
Canonical Wnt signaling was induced in MIO-M1 cells with recombinant Wnt3a (100 ng/ml) for 24 h. The cells were harvested and total RNA was isolated using Trizol phenol-based extraction (Invitrogen, Carlsbad, California, USA), cDNA was synthesized using Thermoscript 
Chloramphenicol acetyl transferase assay
The MIO-M1 Muller glia cell line was transfected with the rat BDNF promoter constructs described in [14] . Pilot assays showed the greatest induction for constructs 2 [rBDNF II 3.7 CAT, using the annotation in [14] ], 4 (rBDNF IV 4.4 CAT), 5 (rBDNF IV 0.4 CAT), and 7 (rBDNF I-III minigene), and these were chosen for further analysis. Twenty-four hours after transfection, the cells were treated with Wnt3a-containing conditioned media, control-conditioned media, or 40 mM LiCl for 24 h. For the TCF4 overexpression experiments, the cells were transfected with a TCF4 or a dominant-negative TCF4 expression plasmid [15] using lipofectamine, and Wnt signaling was induced by Wnt3a or LiCl for 24 h. The chloramphenicol acetyl transferase (CAT) assays were performed using the FAST CAT green (deoxy) Chloramphenicol Acetyltransferase Assay kit (Invitrogen), according to the manufacturer's directions. In brief, the cells were washed with PBS and scraped into lysis solution (40 mM Tris-HCl pH 7.4, 1 mM EDTA, 180 mM NaCl), centrifuged, and resuspended in 0.25 M Tris-HCl pH 7.4. The cells were lysed by multiple rounds of freeze-thaws, centrifuged, and the supernatant was collected. FAST CAT substrate was added, followed by the addition of freshly prepared acetyl CoA and the reactions were incubated for 5 h at 371C. After the reactions were terminated using ice-cold ethyl acetate, the solvent was evaporated and the residues were dissolved in a small volume of ethyl acetate. Chromatography was performed using a silica gel thin layer chromatographic plate in a chromatography chamber filled with a chloroform : methanol solution (85 : 15 v/v). After the solvent ascended, the plate was air dried and scanned with a fluorescence scanner (Typhoon; Amersham Bioscience, Piscataway, New Jersey, USA). Spot intensity was measured and calculated using NIH ImageJ software [16] and the amount of product was calculated and compared with a promoterless CAT plasmid.
Statistical analysis
Values are reported as mean plus SD. For the CAT assays, an unpaired t-test or one-way analysis of variance and the Tukey posttest were used for statistical analyses. The differences were considered statistically significant when the P-value was less than 0.05.
Results
The aim of this study was to characterize BDNF regulation at the transcriptional level. To determine whether BDNF is a direct target of Wnt signaling, our approach was to first examine whether TCF/LEF elements are present within the BDNF gene and then to confirm Wnt-dependent regulation by expression analyses and promoter assays. The rat BDNF transcript contains eight 5 0 untranslated exons and one protein-coding 3 0 exon; four of the untranslated exons contain promoters that control gene expression [14, 17] . TCF/LEFbinding motifs were searched for in the entire 3.9 kb coding region of the rat BDNF gene as well as the 1 kb sequences upstream of the transcription start site. The 7-base consensus motif for TCF/LEF (WWCAAWG) was analyzed first [9, 10] . As shown in Fig. 1 , there are seven copies of the TCF/LEF motif in the positive and negative strands and this number was higher than predicted due to chance (significance level P = 0.042). We also analyzed the BDNF gene for the presence of the seven-base consensus motif for TCF4 (TTCAAAG) [9] [10] [11] and identified three predicted binding sites in BDNF (significance level P = 0.00696). Therefore, the identification of TCF/LEF sites within the BDNF gene provides the first line of evidence that BDNF is a potential direct target of Wnt signaling, with the possibility that even more TCF/LEF sites may lie outside the analyzed region.
Muller glia cells are a retina-specific glia type that is essential to tissue differentiation, neuronal survival, and homeostasis. During injury to the retina, Muller glia secrete BDNF and other growth factors that protect neurons from further damage. We previously demonstrated robust Wnt3a-mediated Wnt signaling in the Muller glia cell line MIO-M1 [6] , indicating that they are an appropriate in-vitro model to study the relationship between Wnt and BDNF pathways. We used CAT reporter promoter assays to quantify induction of the BDNF promoters. The CAT constructs contain specific BDNF promoter regions, as described above and in Timmusk et al. [14] . Each CAT construct was transfected into the glia cell line and the cells were treated with Wnt3a, 40 mM LiCl, or control. As shown in Fig. 2 , construct 2, which contains a 3.7 kb fragment of exon II and its 5 0 flanking region (promoter II), had the highest induction with Wnt3a (the ratio of Wnt3a/control was 3.6, n = 4, P = 0.023). In contrast, LiCl, another activator of the Wnt pathway, showed the highest induction of construct 5, which contains promoter III (the LiCl/ control ratio was 1.9, n = 4, P = 0.044). Interestingly, there was a large repression of construct 4, which contains a 5.5 kb fragment of exon IV (LiCl/control 0.07, P = 0.005). The difference between the response to Wnt3a and LiCl, especially the lack of activation of construct 2 by LiCl, is unknown but we speculate that it may involve their different mechanisms of action: Wnt3a is an upstream ligand and is specific to the Wnt pathway, whereas LiCl induces Wnt signaling by inhibiting GSK3b and can stimulate other signaling pathways, potentially including pathways that could repress construct 2.
To test the specificity of Wnt-dependent induction of BDNF, we transfected the glia cells with dominantnegative TCF4 (DN-TCF4) [15] , followed by treatment with Wnt3a and LiCl. The control transfection was wildtype TCF4 [15] . DN-TCF4 reduced Wnt3a-dependent induction of BDNF construct 2 (P < 0.01) and also reduced LiCl-dependent induction (P < 0.01) of BDNF construct 5.
Finally, to quantify the effect of Wnt signaling on BDNF transcript levels, the glia cells were treated with the Wnt ligand Wnt3a to induce Wnt signaling and gene expression levels were compared between Wnt3a-treated and untreated cells. The expression of BDNF, its receptor TrkB, and the downstream BDNF-regulated prosurvival gene Bcl-2 were examined by quantitative PCR. The BDNF primers amplified the 3 0 untranslated region, which is common to all splice variants [17] , and will detect all BDNF transcripts. As shown in Fig. 3 , the expressions of BDNF and several other genes in the BDNF signaling pathway were induced by Wnt3a. Therefore, the expression analysis, together with the TCF/LEF motif identification and inhibition by DN-TCF4, indicates that BDNF is a direct target of the Wnt pathway.
Discussion
BDNF enhances the survival of neurons exposed to multiple injuries, including oxidative stress, axotomy, and hypoxic ischemic injury [1, 2] . However, prolonged exposure to BDNF can directly induce the death of neurons and nonneuronal cells [18, 19] and increases vulnerability to oxygen/glucose deprivation [20] . Therefore, precise control of BDNF levels and activity is critical. Although much effort has been focused on the downstream signaling cascades induced by BDNF and other growth factors, a key question is the identity of the upstream signaling pathways that regulate growth factor induction. In this study, we demonstrated that the Wnt signaling pathway directly induces BDNF expression in Muller glia, which are the principal supportive glia in the retina that are the central mediators of growth factormediated protection in the retina [3] . Therefore, our data suggest that Wnt signaling contributes to, and may amplify, the intrinsic neurotrophic protective tissue response during injury. Our results add to the understanding of how BDNF is regulated in glia and highlight cross-talk between prosurvival pathways. Despite the number of TCF/LEF-binding sites identified in BDNF, the overall expression increase measured by quantitative PCR was moderate. This finding may indicate that cellular injury is required for a higher induction level or it could be a consequence of the invitro assay system. Although we found that BDNF was induced by Wnt signaling without the requirement for injury in cell culture, induction of BDNF by the nontypical Wnt activator Norrin in rat retinal glia was only observed when Norrin was combined with N-methyl-D-aspartate injury, although this was also at moderate levels (approximately three-fold) [8] .
Other factors are also known to regulate BDNF, including upstream stimulatory factors 1 and 2, which bind to Ca 2 + -responsive E-box elements in the BDNF promoter in response to calcium signaling [21] . Our data do not exclude the possibility that indirect regulation of BDNF expression by Wnt signaling may occur, through Wntdependent induction of other signaling pathways. The finding that upstream stimulatory factor 1 is a direct target of TCF4 [11] suggests that Wnt may also control BDNF expression indirectly, as a secondary level of control. Similarly, dopamine-induced transcription of BDNF involves cAMP/CREB binding to the BDNF promoter III [14] , and we identified TCF/LEF motifs in CREB proteins (Yi and Hackam, unpublished observations).
Combining expression analyses with the identification of TCF-binding sites within the promoters of candidate genes provides an indication of potential direct targets of Wnt signaling. TCF/LEF proteins are central to the regulation of gene expression by canonical Wnt signaling, although Wnt-independent activity of TCF/LEF proteins has been reported [22] . For example, recent evidence suggests that TCF proteins act independently of Wnt/b-catenin in the central retina during embryonic development in the mouse [23] . TCF/LEF may also control chromatin structure through their binding motifs [11] . Therefore, the possibility exists that BDNF could also be regulated by TCF4 in the absence of Wnt pathway activation.
A study by Hatzis et al. [11] demonstrated a significant correlation between TCF4 binding to a target gene and upregulation of the corresponding transcripts. Therefore, identifying TCF/LEF-binding sites within a promoter region predicts direct regulation by Wnt signaling. Identification of the specific binding elements that are used will require extensive chromatin immunoprecipitation and mutagenesis studies. The number of putative TCF/LEF sites within BDNF may have been underestimated in our analysis because many transcription factors bind to regions other than the proximal promoter [11] . Additional sites outside the 1 kb region may be used and may more precisely regulate BDNF expression. Extending our search to cover more than the proximal region would likely identify more sites, but would not alter our overall conclusions.
The canonical Wnt pathway regulates neuronal viability and differentiation, stem cell proliferation, and regeneration in the retina and elsewhere in the CNS. Identifying genes regulated by Wnt/TCF/LEF, such as BDNF, provides important clues into how the Wnt pathway exerts its phenotypic effects. Recent reports have demonstrated that Wnt signaling regulates the expression of other growth factors, including NT-3 in the limb bud [24] , GDNF during kidney development, and TGFb during chondrogenesis [25] . Wnt3a also upregulated NT3, NGF, and BDNF in a rat retinal ganglion cell line [7] . Both Wnt signaling pathway proteins and BDNF are present in Muller glia, implying that BDNF can be considered a potential target of Wnt ligands in vivo. Confirming that BDNF is a factor in Wnt-dependent activities will require analysis in more complex systems, including animal models, to assess the regulation of BDNF at the protein and activity level, and to determine the importance of Wnt-induced BDNF in specific situations such as differentiation, injury, or regeneration. 
